The origin of the additional chromosome in 26 trisomy 16 spontaneous abortions was studied using DNA probes for chromosome 16, including a probe for centromeric a satellite sequences. We were able to determine the parent and meiotic stage of origin of trisomy in 22 cases, with all being attributable to maternal meiosis I non-disjunction. Furthermore, in each of the remaining four cases the results were compatible with this origin. Thus, it is likely that the high incidence of trisomy 16 results from an abnormal process acting at maternal meiosis I which more frequently involves chromosome 16 than other similar sized chromosomes. In studies of recombination, we found little evidence for an association between reduced or absent recombination and chromosome 16 non-disjunction; however, we were unable to rule out an effect of hyperrecombination.
the high incidence of trisomy 16 results from an abnormal process acting at maternal meiosis I which more frequently involves chromosome 16 than other similar sized chromosomes. In studies of recombination, we found little evidence for an association between reduced or absent recombination and chromosome 16 non-disjunction; however, we were unable to rule out an effect of hyperrecombination.
Trisomy 16 is the most commonly identified trisomy in man, occurring in at least 1% of all clinically recognised pregnancies.' Despite its high frequency, little is known about the parent or meiotic stage of origin of the additional chromosome. Results of chromosomeheteromorphism analyseshaveimplicated maternal non-disjunction as the most likely source of trisomy,' but these studies have been hindered by the imprecision of the cytogenetic technique and the low level of polymorphism associated with the chromosome 16 cytogenetic marker.
We recently initiated DNA marker studies to determine the parent and meiotic origin of the extra chromosome in trisomy 16 spontaneous abortions and to assess the possibility that hypo-or hyper-recombination is associated with the non-disjunctional event. In the present report, we summarise our observations on an initial series of 26 fetuses and show that virtually all trisomy 16 results from nondisjunction at maternal meiosis I.
Materials and methods
The study population consisted of 26 trisomy 16 abortuses, 12 of which were ascertained in a cytogenetic survey of spontaneous abortions conducted in Hawaii and 14 in a similar study now under way at Emory University, Atlanta, GA. Preliminary results on the 12 Hawaiian cases were reported previously2; an additional three cases described in that report were excluded from the present study because of insufficient proband DNA. The methodology for the collection, culturing, and cytogenetic analysis of tissue samples is almost identical for the Hawaii and Atlanta studies, and has been described in detail elsewhere. 3 DNA was extracted from fetal tissue and parental blood samples and processed for DNA hybridisation studies using previously described techniques. 4 The parental origin of the additional chromosome was evaluated with eight probes detecting restriction fragment length polymorphisms at chromosome 16 loci: pEKMAD2. 1 (D16S83), CMM65 (D16S84), 16/32 (D16S35), 16/12 (D16S36), hp2alpha (HP), pEKXp3B (CTRB), p79-2-23 (D16S7), and pHUAPRT (APRT). 5 The meiotic stage of origin of trisomy was studied with pSE16-2 (D16Z2), which detects highly polymorphic a satellite sequences at the centromere of chromosome 16.6 For this analysis, DNA samples from the trisomic fetus and parents were digested with EcoRV and processed for hybridisation studies as for the other probes. Non-disjunction was scored as being of meiosis I origin if all centromeric restriction fragments in the parent of origin were present in the trisomic fetus, and of meiosis II origin if only a subset of the fragments were present in the fetus. This scoring system assumes that the parent of origin is heterozygous; however, this seems a safe assumption, since (1) Greig et aP6 were unable to detect identical pSE16-2/EcoRV restriction patterns among approximately 30 unrelated persons, and (2) in the present study, in 22 of 23 cases in which the parental origin of trisomy was determined, the trisomic fetus clearly inherited only a subset of the centromeric restriction fragments from the parent who had contributed a single chromosome 16. For trisomies in which we were able to determine the parent and meiotic stage of origin, we evaluated the frequency of crossing over between the two nondisjoined chromosomes by (1) identifying heterozygous loci in the parent of origin of trisomy, (2) studying these loci in the trisomic offspring to determine if heterozygosity had been maintained, or had been reduced to homozygosity, and (3) We were also able to obtain some information on each of the four remaining trisomies. In K3021, a 45,X/46,X,+16 mosaic, the additional chromosome was maternally derived and, as maternal heterozygosity at two loci was maintained in the trisomic fetus, the trisomic line must have originated in meiosis. However, the centromeric marker was uninformative and therefore we were not able to distinguish between a meiosis I and II error. In S9, we were unable to determine the parental origin of trisomy, but all parental restriction fragments detected by the centromeric probe were present in the fetus. Thus, the additional chromosome 16 presumably resulted from non-disjunction at meiosis I. In S374 and S382, parental origin studies were uninformative. However, in each case the fetus had inherited all of the maternal, but only a subset of the paternal, centromeric restriction fragments. Thus, for these two cases the trisomy must have originated from an error at maternal meiosis I or at paternal meiosis II. this is consistent with data on maternal age. Risch et a18 have shown that trisomy 16 has a completely (log) linear increase in frequency with age, with no evidence for a maternal age independent component and this has been confirmed by Morton et al.9 In this respect, trisomy 16 is unlike other trisomies involving similar sized chromosomes. From this, Risch et al8
suggested that there may be a single underlying mechanism of origin for trisomy 16 which is different from the mechanisms associated with trisomies for the other small chromosomes.
The results of the present study support this interpretation. In each of 22 cases of trisomy 16 in which we were able to determine both the parent and meiotic stage of origin, the additional chromosome resulted from non-disjunction at maternal meiosis I.
In four other cases in which we were unable to specify the parent or stage of origin or both, our observations were consistent with a maternal meiosis I error. Thus, in all 26 cases our results were compatible with maternal meiosis I non-disjunction. Maternal errors predominate in other trisomies that have been studied with DNA markers,2 10 11 but to our knowledge no other trisomy has as high a proportion of cases of maternal origin. Thus, it may be that the high incidence of trisomy 16 is attributable to an abnormal process acting at maternal meiosis I which is more likely to disrupt disjunction of chromosome 16 than other chromosomes.
In the second aspect of our study, we were interested in determining whether or not chromocome 16 non-disjunction might be related to abnormally low or high levels of recombination. Recent studies from our laboratory and others suggested an association between failure to recombine and maternal meiosis I non-disjunction for the XX'2 and chromosome 21 bivalents'3 (Hassold, 
